★★★★★★★★★★★★★★★★★★★★★★★★★★★★★★★★★★★★★★★★★★★★★★★★★★Open research. Global perspectives.
Medical Sciences OPEN ACCESS

Clinical And Functional Effectiveness Of Endonasal Electrophoresis In Combination With Electrostimulation In Complex Therapy Of Glaucomatous Optic Neuropathy

Temur Saidov
Head Of The Department Of Ophthalmology, Faculty Of Postgraduate Education Samarkand State Medical Institute, Uzbekistan
Nodira Yangieva
PhD, Associate Professor Department Of Ophthalmology With The Course Of Gynecology, Tashkent State Dental Institute, Uzbekistan
Firdavs Khamidullaev
Assistant Of The Course Of Ophthalmology, Faculty Of Postgraduate Education Samarkand State Medical Institute, Samarkand Eye Care Hospital, Uzbekistan
Janna Nazarova
Associate Professor, Department Of Neurology Tashkent Institute Of Postgraduate Medical Education, Uzbekistan
Okhun Nizomov
1st Year Master's Of The Department Of Ophthalmology Samarkand State Medical Institute, Uzbekistan
tajmspr 2021
VOL. 3 / NO. 03 MARCH
VOLUME 3
ISSUE 03
YEAR 2021
PAGES 12-19

Abstract

The aim of the study was the clinical and functional assessment of the complex treatment of glaucomatous optic neuropathy with the administration of the drug tanakan in the form of endonasal electrophoresis in combination with electrical stimulation according to IST and ultrasound Doppler mapping. We examined 43 (74 eyes) patients with GON aged from 58 to 76 years. The results of the study showed that this method effectively delays the development of optic nerve atrophy and, along with the improvement of visual functions, lengthens the positive effect of the main treatment, which was confirmed by a significant improvement in hemodynamic parameters according to the ultrasound Doppler study.

Keywords

Glaucoma optic neuropathy retinoprotection endonasal electrophoresis electrical stimulation

Downloads

Download data is not yet available.

References

  1. Libman E.S., Kaleeva E.V. The state and dynamics of disability due to visual impairment in Russia, Congress of ophthalmologists of Russia, 9th: abstracts. Report Moscow:, 2010.
  2. Flammer D. Glaucoma // Glaucoma. World Wide Printing, 2003, ― P.345
  3. Kurysheva N.I. Glaucoma optic neuropathy, - Moscow: MED press-inform, 2006. – P.136.
  4. Alekseev V.N., Kozlova N.V. The use of Retinalamin in patients with primary open-angle glaucoma // Glaucoma. 2013. №1, P. 49-52.
  5. Neroev V.V., Erichev V.P., Lovpache D.N. Peptides in neuroprotective therapy of patients with primary open-angle glaucoma with normal ophthalmotonus // Retinalamin. Neuroprotection in ophthalmology.2012. №6. P.37.
  6. Basinsky S.P., Basinsky A.S. The effectiveness of complex therapy of patients with primary unstabilized open-angle glaucoma with “normalized” ophthalmotonus // Clinical Ophthalmology. - 2015. – Тashkent: 6, №2. - P.62-64
  7. Zakharov V.V., Yakhno N.N. The use of Tanakan in violation of cerebral and peripheral circulation // Russ. Medic, jurnal. – 2011. – Tashkent:.9 – P.6–8.
  8. The effectiveness of percutaneous electrical stimulation in the treatment of patients with primary open-angle glaucoma / T.G. Kamenskikh, E.V. Veselova, Yu.A. Dubina // Modern technologies of the XXI century: Sat. scientific tr. - Saratov, 2009. – P. 53-54.
  9. The effectiveness of percutaneous electrical stimulation in the treatment of patients with primary open-angle glaucoma / T.G. Kamenskikh, E.V. Veselova, Yu.A. Dubina // Russian National Forum. Sat. scientific tr. – Moscow:, 2008. – P. 487-489
  10. Choplin N.T., Lundy D. C. Atlas of glaucoma, second edition. 2007.
  11. Doshi V., Ying L.M., Azen S.P., Varma R. Sociodemographic, family history, and lifestyle risk factors for open-angle glaucoma and ocular hypertension. Ophthalmology, 2008; 115(1):639–647
  12. Hara Y., Torlu N. Clinical potential of lamerzine, a Ca 2+ channel blocker as an antiglaucoma drug: effects on ocular circulation and retinal neuronal damage // Cardiovascular Drug Reviews. - 2014. - Vol. 22. - P. 199-214.
  13. Lugasi A. Additional information to the in vitro antioxidant activity of Ginkgo biloba // L. hytother Res. - Vol. 13. - P. 160-162.
  14. Quaranta L., Betelli S., Uva M. Effect of Ginkgo bilobaextract on preexisting visual field damage in normal tension glaucoma // Ophthalmology. - 2013. - Vol. 110. - P.359-362
  15. Brian Chua, Ivan Goldberg. Neuroprotective agents in glaucoma therapy: Recent developments and future directions// Rev. Ophthalmol.- 2016.-v.5(5).-p.627-636.
  16. Nazarova, J. (2021). Respiratory Disorders during Sleep with Chronic Obstructive Pulmonary Disease. International Journal Of Medical Science And Clinical Research Studies, 1(1), 18-23.
  17. Nazarova, J. (2021). Features of Cognitive Status in Patients with Venous Cerebral Dysfunction on the Background of Chronic Cerebral Ischemia. Annals of the Romanian Society for Cell Biology, 4553-4557.
  18. Nazarova, J. (2021). Estimation of Clinical and Neurophysiological State of Cognitive Functions during Epilepsy in the Background of Anti-Consumer Therapy. International Journal Of Medical Science And Clinical Research Studies, 1(1), 01-04.
  19. Nazarova, J. (2021). Features of Cognitive Disorders in Adults Epilepsy. International Journal Of Medical Science And Clinical Research Studies, 1(1), 09-13.
CONTINUE EXPLORING

Most read articles by the same author(s)

Explore other published research by the authors of this article.